Intelligent Bio Solutions begins FDA study for drug screening device

June 2, 2026 8:30 AM

Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the start of a multi-site method comparison study to support its FDA 510(k) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found